These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 6443808

  • 1. Chlorpropamide-induced hyponatremia: incidence and risk factors.
    Kadowaki T, Hagura R, Kajinuma H, Kuzuya N, Yoshida S.
    Diabetes Care; 1983; 6(5):468-71. PubMed ID: 6443808
    [Abstract] [Full Text] [Related]

  • 2. Favorable effects of glibenclamide in a patient exhibiting idiosyncratic hepatotoxic reactions to both chlorpropamide and tolbutamide.
    Rumboldt Z, Bota B.
    Acta Diabetol Lat; 1984; 21(4):387-91. PubMed ID: 6442088
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z, Obaidullah S, Fayyaz-ud-Din.
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chlorpropamide-induced hyponatremia in the veteran population.
    Hirokawa CA, Gray DR.
    Ann Pharmacother; 1992 Oct; 26(10):1243-4. PubMed ID: 1421649
    [Abstract] [Full Text] [Related]

  • 7. Chlorpropamide-induced hyponatremia.
    Piters K.
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1085-7. PubMed ID: 993312
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinico-statistical studies of the use of oral hypoglycemic agents in the therapy of diabetes: critical evaluation of their effectiveness and tolerance].
    Torri A, Zanni A, Roncaia R, Di Saverio S.
    Clin Ter; 1977 Jul 15; 82(1):45-56. PubMed ID: 409583
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P, Oksala H, Pitkäjärvi T.
    Arzneimittelforschung; 1985 Jul 15; 35(10):1596-9. PubMed ID: 3935120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diabetes mellitus treated with chlorpropamide and tolbutamide. A four-year clinical study.
    Powell T, Howells L.
    Diabetes; 1966 Apr 15; 15(4):269-75. PubMed ID: 5929542
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.